Literature DB >> 9347896

Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein.

L J Bain1, J B McLachlan, G A LeBlanc.   

Abstract

The multixenobiotic resistance phenotype is characterized by the reduced accumulation of xenobiotics by cells or organisms due to increased efflux of the compounds by P-glycoprotein (P-gp) or related transporters. An extensive xenobiotic database, consisting primarily of pesticides, was utilized in this study to identify molecular characteristics that render a xenobiotic susceptible to transport by or inhibition of P-gp. Transport substrates were differentiated by several molecular size/shape parameters, lipophilicity, and hydrogen bonding potential. Electrostatic features differentiated inhibitory ligands from compounds not catagorized as transport substrates and that did no interact with P-gp. A two-tiered system was developed using the derived structure-activity relationships to identify P-gp transport substrates and inhibitory ligands. Prediction accuracy of the approach was 82%. We then validated the system using six additional pesticides of which tow were predicted to be P-gp inhibitors and four were predicted to be noninteractors, based upon the structure-activity analyses. Experimental determinations using cells transfected with the human MDR1 gene demonstrated that five of the six pesticides were properly catagorized by the structure-activity analyses (83% accuracy). Finally, structure-activity analyses revealed that among P-gp inhibitors, relative inhibitory potency can be predicted based upon the surface area or volume of the compound. These results demonstrate that P-gp transport substrates and inhibitory ligands can be distinguished using molecular characteristics. Molecular characteristics of transport substrates suggest that P-gp may function in the elimination of hydroxylated metabolites of xenobiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347896      PMCID: PMC1470197          DOI: 10.1289/ehp.97105812

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  25 in total

1.  Reversal of multidrug resistance by lipophilic drugs.

Authors:  E Hofsli; J Nissen-Meyer
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

Review 2.  The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics.

Authors:  R P Oude Elferink; P L Jansen
Journal:  Pharmacol Ther       Date:  1994-10       Impact factor: 12.310

Review 3.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

4.  Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

Authors:  J J Smit; A H Schinkel; R P Oude Elferink; A K Groen; E Wagenaar; L van Deemter; C A Mol; R Ottenhoff; N M van der Lugt; M A van Roon
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

5.  A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.

Authors:  G C Yeh; J Lopaczynska; C M Poore; J M Phang
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

6.  Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.

Authors:  J G Christensen; G A LeBlanc
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

7.  Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography.

Authors:  V Debal; H Morjani; J M Millot; J F Angiboust; B Gourdier; M Manfait
Journal:  J Chromatogr       Date:  1992-10-02

8.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

Authors:  A H Schinkel; J J Smit; O van Tellingen; J H Beijnen; E Wagenaar; L van Deemter; C A Mol; M A van der Valk; E C Robanus-Maandag; H P te Riele
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

9.  Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland.

Authors:  M Ichikawa-Haraguchi; T Sumizawa; A Yoshimura; T Furukawa; S Hiramoto; M Sugita; S Akiyama
Journal:  Biochim Biophys Acta       Date:  1993-11-28

10.  Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

Authors:  C K van Kalken; H J Broxterman; H M Pinedo; N Feller; H Dekker; J Lankelma; G Giaccone
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  17 in total

1.  Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.

Authors:  Prateek Bhatia; Michel Bernier; Mitesh Sanghvi; Ruin Moaddel; Roland Schwarting; Anuradha Ramamoorthy; Irving W Wainer
Journal:  Xenobiotica       Date:  2012-03-08       Impact factor: 1.908

Review 2.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

3.  An in silico approach for screening flavonoids as P-glycoprotein inhibitors based on a Bayesian-regularized neural network.

Authors:  Yong-Hua Wang; Yan Li; Sheng-Li Yang; Ling Yang
Journal:  J Comput Aided Mol Des       Date:  2005-03       Impact factor: 3.686

4.  Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031.

Authors:  Jong Soo Woo; Chang Hyun Lee; Chang Koo Shim; Sung-Joo Hwang
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

5.  Assessment of the disposition of chiral polychlorinated biphenyls in female mdr 1a/b knockout versus wild-type mice using multivariate analyses.

Authors:  Bartłomiej Milanowski; Janina Lulek; Hans-Joachim Lehmler; Izabela Kania-Korwel
Journal:  Environ Int       Date:  2009-11-17       Impact factor: 9.621

6.  Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

Authors:  Shilpa Narayan; Janet S Sinsheimer; Kimberly C Paul; Zeyan Liew; Myles Cockburn; Jeff M Bronstein; Beate Ritz
Journal:  Environ Res       Date:  2015-10-19       Impact factor: 6.498

7.  Killing them with kindness? In-hive medications may inhibit xenobiotic efflux transporters and endanger honey bees.

Authors:  David J Hawthorne; Galen P Dively
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

8.  Nitromusk and polycyclic musk compounds as long-term inhibitors of cellular xenobiotic defense systems mediated by multidrug transporters.

Authors:  Till Luckenbach; David Epel
Journal:  Environ Health Perspect       Date:  2005-01       Impact factor: 9.031

9.  Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells.

Authors:  Feifei Xu; Fengliang Wang; Ting Yang; Yuan Sheng; Ting Zhong; Yun Chen
Journal:  Cancer Cell Int       Date:  2014-12-21       Impact factor: 5.722

10.  Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structure.

Authors:  Sascha C T Nicklisch; Steven D Rees; Aaron P McGrath; Tufan Gökirmak; Lindsay T Bonito; Lydia M Vermeer; Cristina Cregger; Greg Loewen; Stuart Sandin; Geoffrey Chang; Amro Hamdoun
Journal:  Sci Adv       Date:  2016-04-15       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.